Press Releases

October 28, 2016

Kite Pharma to Present at November 2016 Investor Conferences

SANTA MONICA, Calif.--(BUSINESS WIRE)-- Kite Pharma, Inc. (Nasdaq:KITE) today announced that management will present at three investor conferences in November:

Credit Suisse 25^th Annual Healthcare Conference

Date: Monday, November 7, 2016
Time: 2:30pm Mountain Time
Location: Phoenix, AZ

Jefferies London Healthcare Conference

Date: Wednesday, November 16, 2016
Time: 10:00am Greenwich Mean Time
Location: London, UK

Stifel 2016 Healthcare Conference

Date: Wednesday, November 16, 2016
Time: 1:30 PM Eastern Time
Location: New York, NY

A live audio webcast of each event will be available on the Investors section of Kite's website, www.kitepharma.com. A replay of each webcast will be available on the website for approximately 30 days.

About Kite Pharma

Kite Pharma, Inc. is a clinical-stage biopharmaceutical company engaged in the development of novel cancer immunotherapy products, with a primary focus on engineered autologous cell therapy (eACT™) designed to restore the immune system's ability to recognize and eradicate tumors. Kite is based in Santa Monica, CA. For more information on Kite Pharma, please visit www.kitepharma.com. Sign up to follow @KitePharma on Twitter at www.twitter.com/kitepharma.

View source version on businesswire.com: http://www.businesswire.com/news/home/20161028005154/en/

Kite Pharma, Inc.
Christine Cassiano
SVP, Corporate Communications & Investor Relations
ccassiano@kitepharma.com
or
Greg Mann
VP, Investor Relations
gmann@kitepharma.com

Source: Kite Pharma, Inc.

News Provided by Acquire Media